Predicting the carcinogenicity of chemicals with alternative approaches: recent advances

Introduction: Alternative approaches to the rodent bioassay are necessary for early identification of problematic drugs and biocides during the development process, and are the only practicable tool for assessing environmental chemicals with no or adequate safety documentation. Areas covered: This review informs on: i) the traditional prescreening through genotoxicity testing; ii) an integrative approach that assesses DNA-reactivity and ability to disorganize tissues; iii) new applications of omics technologies (ToxCast/Tox21 project); iv) a pragmatic approach aimed at filling data gaps by intrapolating/extrapolating from similar chemicals (read-across, category formation). The review also approaches the issue of the concerns about false-positive and false-negative results that prevents a wider acceptance and use of alternatives. Expert opinion: The review addresses strengths and limitations of various proposals, and concludes on the need of differential approaches to the issue of false negatives and false positives. False negatives can be eliminated or reduced below the variability of the animal assay with conservative quantitative structure−activity relationships or in vitro tests; false positives can be cleared with ad hoc mechanistically based follow-ups. This framework can permit a reduction of animal testing and a better protection of human health.

[1]  Alison Abbott Animal testing: More than a cosmetic change , 2005, Nature.

[2]  Raffaella Corvi,et al.  How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. , 2007, Mutation research.

[3]  E Zeiger,et al.  Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance. , 1998, Regulatory toxicology and pharmacology : RTP.

[4]  Olga Tcheremenskaia,et al.  The new ISSMIC database on in vivo micronucleus and its role in assessing genotoxicity testing strategies. , 2012, Mutagenesis.

[5]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[6]  Patricia L Bishop,et al.  Animal Use and Lessons Learned in the U.S. High Production Volume Chemicals Challenge Program , 2012, Environmental health perspectives.

[7]  Romualdo Benigni,et al.  Alternative strategies for carcinogenicity assessment: an efficient and simplified approach based on in vitro mutagenicity and cell transformation assays. , 2011, Mutagenesis.

[8]  H. van Steeg,et al.  Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach. , 2009, Mutation research.

[9]  H. Yamasaki,et al.  Non-genotoxic mechanisms of carcinogenesis: studies of cell transformation and gap junctional intercellular communication. , 1995, Toxicology letters.

[10]  Romualdo Benigni,et al.  Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology. , 2011, Chemical reviews.

[11]  Paule Vasseur,et al.  OECD Detailed Review Paper (DRP) number 31 on "Cell Transformation Assays for Detection of Chemical Carcinogens": main results and conclusions. , 2012, Mutation research.

[12]  Usha Sankar The delicate toxicity balance in drug discovery , 2005 .

[13]  Melvin E Andersen,et al.  Toxicity Testing in the 21st Century: Implications for Human Health Risk Assessment , 2009, Risk analysis : an official publication of the Society for Risk Analysis.

[14]  T. Stedeford,et al.  Cancer risk assessment : chemical carcinogenesis, hazard evaluation, and risk quantification , 2010 .

[15]  Romualdo Benigni,et al.  Evaluation of the Toxicity Forecasting Capability of EPA's ToxCast Phase I Data: Can ToxCast In Vitro Assays Predict Carcinogenicity? , 2013, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[16]  R. Benigni,et al.  Nongenotoxic carcinogenicity of chemicals: mechanisms of action and early recognition through a new set of structural alerts. , 2013, Chemical reviews.

[17]  H. Kubinyi Drug research: myths, hype and reality , 2003, Nature Reviews Drug Discovery.

[18]  T. Knudsen,et al.  A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. , 2012, ALTEX.

[19]  M. Aardema,et al.  ECVAM prevalidation study on in vitro cell transformation assays: general outline and conclusions of the study. , 2012, Mutation research.

[20]  Robert J Kavlock,et al.  In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  R. Harbison Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Evaluation, and Risk Quantification , 2011, Environmental Health Perspectives.

[22]  K. Kitchin,et al.  Carcinogenicity: Testing: Predicting, and Interpreting Chemical Effects , 1998 .

[23]  David Kirkland,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo. , 2005, Mutation research.

[24]  Yin-tak Woo,et al.  OncoLogic: A Mechanism-Based Expert System for Predicting the Carcinogenic Potential of Chemicals , 2005 .

[25]  J. Huff,et al.  Long‐Term Chemical Carcinogenesis Bioassays Predict Human Cancer Hazards: Issues, Controversies, and Uncertainties , 1999, Annals of the New York Academy of Sciences.

[26]  Ann Richard,et al.  ACToR--Aggregated Computational Toxicology Resource. , 2008, Toxicology and applied pharmacology.

[27]  Romualdo Benigni,et al.  Alternatives to the carcinogenicity bioassay for toxicity prediction: are we there yet? , 2012, Expert opinion on drug metabolism & toxicology.

[28]  J. Huff,et al.  Scientific concepts, value, and significance of chemical carcinogenesis studies. , 1991, Annual review of pharmacology and toxicology.

[29]  T W Schultz,et al.  Using chemical categories to fill data gaps in hazard assessment , 2009, SAR and QSAR in environmental research.

[30]  Yin-tak Woo,et al.  Mechanisms of Action of Chemical Carcinogens and Their Role in Structure-Activity Relationships (SAR) Analysis and Risk Assessment 2 , 2003 .

[31]  M. Fujita,et al.  Efficient immortalization of primary human cells by p16INK4a‐specific short hairpin RNA or Bmi‐1, combined with introduction of hTERT , 2007, Cancer science.

[32]  Nigel Greene,et al.  Early toxicity screening strategies. , 2009, Current opinion in drug discovery & development.

[33]  D. Lai,et al.  Reducing Carcinogenicity and Mutagenicity Through Mechanism-Based Molecular Design of Chemicals , 2012 .

[34]  D. Dix,et al.  The ToxCast program for prioritizing toxicity testing of environmental chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  C. Schmidt Testing for carcinogens: shift from animals to automation gathers steam--slowly. , 2009, Journal of the National Cancer Institute.

[36]  Olga Tcheremenskaia,et al.  In vitro cell transformation assays for an integrated, alternative assessment of carcinogenicity: a data-based analysis. , 2013, Mutagenesis.

[37]  P. Vasseur,et al.  Epigenetic events during the process of cell transformation induced by carcinogens (review). , 1999, Oncology reports.

[38]  Olga Tcheremenskaia,et al.  IARC classes 1 and 2 carcinogens are successfully identified by an alternative strategy that detects DNA-reactivity and cell transformation ability of chemicals. , 2013, Mutation research.

[39]  Computational methods to predict drug safety liabilities. , 2001, Current opinion in drug discovery & development.

[40]  Paul L. Carmichael,et al.  Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs , 2011, Mutagenesis.

[41]  Michael B. Black,et al.  A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[42]  R. T. Bunch,et al.  The Syrian Hamster Embryo (SHE) Cell Transformation Assay: Review of the Methods and Results , 2001, Toxicologic pathology.

[43]  Romualdo Benigni,et al.  Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens , 2003 .